Evidence map›Paper›PMID 28756728›Full record

ReviewExpert review of respiratory medicine2017

Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders.

Smita Das, Judith J Prochaska

Abstract readReview
In one paragraph

Review in Expert review of respiratory medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Interventions for smoking cessation in inpatient psychiatry settings.The Cochrane database of systematic reviews · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Changing Process of Women's Smoking Status Triggered by Pregnancy.International journal of environmental research and public health · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Smita Dasa Psychiatry and Behavioral Sciences , Stanford University School of Medicine , Stanford , CA , USA.
Judith J Prochaskab Stanford Prevention Research Center , Stanford University School of Medicine , Stanford , CA , USA.

Funding

Technology Innovations for Supporting Health in Alaska Native PeopleR01HL117736 · NHLBI · STANFORD UNIVERSITY · PI BENOWITZ, NEAL L, PROCHASKA, JUDITH J. · 2014 to 2018
$3.8M
Social Media Technology for Treating Tobacco AddictionR01CA204356 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI PECHMANN, CORNELIA, PROCHASKA, JUDITH J. · 2016 to 2020
$2.6M
NCI NIH HHS R01 CA204356NHLBI NIH HHS R01 HL117736
6 · The paper itself

Abstract

introductionTobacco remains the leading preventable cause of death in the US, accounting for over 520,000 deaths annually. While the smoking prevalence has declined over the past 50 years, those with mental illness and addictive disorders continue to smoke at high levels and with significant tobacco-related health problems. Areas covered: This review highlights the epidemiology, contributing factors, and evidence-base for intervening upon tobacco use in those with mental illness and addictive disorders. Historically underprioritized, a growing body of literature supports treating tobacco within mental health and addiction treatment settings. Critically, treating tobacco use appears to support, and not harm, mental health recovery and sobriety. This review also summarizes novel, emerging approaches to mitigate the harms of cigarette smoking. Expert commentary: People with mental illness and addictive disorders have a high prevalence of tobacco use with serious health harms. Treating tobacco use is essential. Evidence-based strategies include individual treatments that are stage-matched to readiness to quit and combine cessation medications with behavioral therapies, supported by smoke-free policies in treatment settings and residential environments. Emerging approaches, with a focus on harm reduction, are electronic nicotine delivery systems and tobacco regulatory efforts to reduce the nicotine content in cigarettes, thereby reducing their addiction potential.

Indexed as

Tobacco Use Cessation DevicesCognitive Behavioral TherapyCytochrome P-450 CYP1A2Electronic Nicotine Delivery SystemsGenome-Wide Association StudyHotlinesHumansMental DisordersNicotinic AgonistsPsychotropic DrugsSmokingSmoking CessationSubstance-Related DisordersSubstance Withdrawal SyndromeSuicidal IdeationTobacco Smoke PollutionCYP1A2 protein, humanCytochrome P-450 CYP1A2Nicotinic AgonistsPsychotropic DrugsTobacco Smoke PollutionCYP1A2dual diagnosise-cigarettemental illnessnicotinenicotine replacement therapyquit-linesmokingsubstance use disordersTobacco

Identifiers

PMID28756728
PMCPMC5790168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.